Management of ASC-US in a 45-Year-Old Female
HPV testing is the preferred approach for managing ASC-US in this 45-year-old woman, with colposcopy reserved only if HPV testing is positive—immediate colposcopy is not indicated. 1
Recommended Management Algorithm
For women over age 20 with ASC-US, three acceptable management options exist, but they are not equal in preference 1, 2:
Preferred Strategy: HPV Triage Testing
- Reflex HPV DNA testing (if liquid-based cytology was used) is the preferred approach 1
- This strategy is most efficient, referring approximately half as many women to colposcopy compared to immediate colposcopy while maintaining equivalent sensitivity for detecting CIN 3 3
If HPV testing is performed:
- HPV Negative: Return to routine screening with repeat cytology at 12 months 1
- HPV Positive: Refer for colposcopy 1, 2
Alternative Strategies (When HPV Testing Unavailable)
Option 2: Repeat Cytology
- Repeat Pap smears at 6-month intervals until two consecutive negative results 1, 2
- Refer to colposcopy if any repeat shows ASC-US or greater 1
- After two negative results, return to routine screening 1
Option 3: Immediate Colposcopy
- Acceptable but not preferred 2
- Consider only if concerns exist about patient adherence to follow-up 2
- High-grade histological changes (CIN 2+) are detected in less than 12% of ASC-US cases at colposcopy 2
Key Evidence Supporting This Approach
The 2006 ASCCP Consensus Guidelines clearly establish that all three options are acceptable, but HPV triage is preferred 1. This preference is based on the ASCUS-LSIL Triage Study (ALTS), which demonstrated that HPV triage is at least as sensitive as immediate colposcopy for detecting CIN 3 while reducing colposcopy referrals by approximately 50% 3.
More recent 2014 guidelines reinforce that current risk for CIN3+ after an ASC-US Pap is below the agreed threshold for immediate colposcopy 4. The risk of CIN 2+ in ASC-US is approximately 9.7% 5, and when HPV negative, the risk drops to less than 2% 6.
Important Caveats
Do NOT use HPV 16/18 genotyping for ASC-US triage—it does not alter management since all HPV-positive ASC-US patients should proceed to colposcopy regardless of genotype 3, 4
Avoid diagnostic excisional procedures (LEEP, cone biopsy) for initial ASC-US management in the absence of histologically diagnosed CIN 2,3—this represents overtreatment 1
If colposcopy is performed and no CIN is identified: Follow with repeat cytology at 12 months or HPV testing at 12 months 1
Clinical Context for This Patient
At age 45, this patient falls squarely within the adult management category where HPV testing provides meaningful risk stratification (unlike adolescents where HPV prevalence is too high to be useful) 1, 3. The guidelines are consistent across multiple authoritative sources (ASCCP 2006, CDC STD Treatment Guidelines 2010, NCCN 2010) that HPV triage is preferred over immediate colposcopy for this age group and clinical scenario.
The bottom line: Perform HPV testing first. Only proceed to colposcopy if HPV positive.